Early Detection Saves Lives.
Ensuring sustainable access to cervical cancer prevention worldwide
What We Stand For
Najla Care International Solutions is a globally oriented organization dedicated to developing and implementing cervical cancer early detection programs. Our mission is to ensure equitable access to preventive screening for women worldwide—particularly in regions with limited medical infrastructure.
604.000+
New cases per year worldwide
340.000+
Annual deaths worldwide
90-70-90
WHO elimination target
Why Prevention Is Essential
Cervical cancer remains one of the leading causes of cancer-related deaths among women worldwide. Each year, hundreds of thousands of women lose their lives to a disease that is largely preventable through early screening and timely intervention. The burden is particularly high in regions with limited access to medical infrastructure.
Healthcare is a right, not a luxury
The Reality
In many cases, cervical cancer can be detected early and effectively treated through regular HPV screening. However, many women do not receive preventive care—often due to high costs, long travel distances, or limited medical infrastructure. As a result, preventable conditions frequently remain undiagnosed for far too long.
The Key Barrier
Many low-income women—often the primary providers for their families—prioritize daily living expenses over preventive healthcare. Even when early symptoms appear, medical check-ups are frequently postponed, as financial pressures and competing responsibilities take precedence.
The Solution
Affordable HPV tests specifically designed to reach women within their own communities. By reducing costs, simplifying access, and offering flexible use options, they enable early diagnosis and contribute sustainably to improved long-term health outcomes.
Our Approach
We combine medical innovation with local programs and international partnerships. Through practical and scalable screening solutions, we support healthcare systems in sustainably integrating early detection and building long-term preventive structures.
Our Solution: CarciScan
CarciScan is an innovative HPV PCR test designed to improve the early detection of cervical cancer, particularly for women with limited access to preventive screening.
The test enables simple and discreet self-sampling, allowing women to collect their sample privately and conveniently. The sample is then analyzed using precise HPV-DNA PCR technology, ensuring highly reliable and accurate results.
Our Impact
Our programs create measurable impact.
Through evidence-based HPV testing solutions, we enable structured access to early cervical cancer detection—sustainable, scalable, and adaptable for global implementation.
Partnerships
Sustainable prevention requires collaboration.
We work closely with medical institutions, NGOs, and institutional partners to establish long-term early detection programs and expand access to preventive care.
Taking Action Together
Sustainable prevention requires collaboration.
We work with partners, institutions, and organizations that share our vision: improving global access to early cancer prevention.
Early detection can only create lasting impact when it is structurally integrated into healthcare systems.
If you would like to integrate our HPV test kits into your facility or establish a screening program, we invite you to contact us via the form or by email.
Our team will be pleased to provide individual, non-binding consultation tailored to your needs.